MEngSc in Biopharmaceutical Engineering

University College Dublin

Ireland, Dublin

University RankQS Ranking

127

Apply Now!

Go to Official Website

Home/Ireland/Dublin /University College Dublin/MEngSc in Biopharmaceutical Engineering

University College Dublin

Ireland , Dublin

Key Facts

Program Level

Master by Course Work

Study Type

Full Time

Delivery

On Campus

Campuses

Main Site

Program Language

English

Start & Deadlines

Next Intake Deadlines25-Sep-2026

Apply to this program

Go to the official application for the university

Duration 1 year(s)

Tuition Fee

EUR 29,500 / year

Next Intake 25-Sep-2026

MEngSc in Biopharmaceutical Engineering

About

Pharmaceutical and Biopharmaceutical manufacturing are key sectors in the Irish economy generating over 50 per cent of GDP. This sector has seen continued and sustained success with a number of high-profile investments in recent years providing excellent job opportunities for graduates. The programme and its academic faculty are closely linked with the National Institute for Bioprocessing Research and Training (NIBRT), which is a global centre of excellence for training and research in bioprocessing.

This MEngSc in Biopharmaceutical Engineering programme provides substantial coverage of scientific, technical, management and regulatory issues associated with this industry. This programme offers an internationally recognised high quality flexible curriculum, which follows the latest developments in science and technology. This programme is suitable for Science and Engineering graduates wishing to obtain a qualification which is highly relevant to the biopharmaceutical industry.

Requirements

Entry Requirements

An honours undergraduate degree (NFQ level 8) with a minimum upper second class honours or international equivalence in a relevant Engineering, Science or Technology programme. However, all applicants will be assessed on a case-by-case basis and relevant or extensive work experience will be taken into account.
Applicants whose first language is not English must also demonstrate English language proficiency of IELTS 6.5 (no band less than 6.0 in each element), or equivalent.
These are the minimum entry requirements – additional criteria may be requested for some programmes

You may be eligible for Recognition of Prior Learning (RPL), as UCD recognises formal, informal, and/or experiential learning. RPL may be awarded to gain Admission and/or credit exemptions on a programme. Please visit the UCD Registry RPL web page for further information. Any exceptions are also listed on this webpage.

English Program Requirements

International English Language Testing System (IELTS)

Taught Master's: A minimum overall score of 7.0 over all components and a minimum of 6.0 in each band on the Academic Version. The non-academic version is not accepted.

Research Programmes: A minimum overall score of 6.5 over all components and a minimum of 6.0 in each band on the Academic Version. The non-academic version is not accepted.

IELTS Indicator: A minimum overall score of 7.0 over all components and a minimum of 6.0 in each band. This test will be accepted for 2022/23 and 2023/24 intake.

Test of English as a Foreign Language (TOEFL)

Taught Master's: A minimum score of 100 is required in the Internet based TOEFL (iBT) with a score of at least 20 in each section.

Research Programmes: A minimum score of 90 is required in the Internet based TOEFL (iBT) with a score of at least 20 in each section.

TOEFL iBT Home: A minimum score of 100 is required with a score of at least 20 in each section.

Duolingo Test of English (DET)

UCD has approved the use of the Duolingo Test of English (DET) for the 2024/25 intake.
An overall score of 130 will be accepted with no section below 110.

Please note that this does not apply to the CEMS MiM / MSc in International Management. In the case of the CEMS MiM the Duolingo English Test will not be accepted.

Career

Graduates from this programme are highly sought after and play an important role in the development, design and operation of biopharmaceutical processes throughout the industry in the coming years. Ireland is a world player in pharmaceutical and biopharmaceutical production.

The pharmaceutical industry in Ireland comprises a mix of international and local companies. Approximately, 120 overseas companies have plants in Ireland, including many of the largest pharmaceutical and biopharmaceutical companies in the world including AbbVie, Amgen, Biomarin, BMS, Genzyme, GSK, Janssen Biologics (Ireland), Merck, Novartis, Pfizer, Regeneron, Roche, Sanofi Shire, and many more. Upon graduation from this programme, you will enjoy an extremely high job placement rate with superlative career opportunities.